Phase 3 trial for the treatment of actinic keratoses on the face and scalp with 3 tubes of Ameluz and the RhodoLED XL lamp
Latest Information Update: 09 Dec 2021
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- Sponsors Biofrontera Pharma GmbH
Most Recent Events
- 09 Dec 2021 New trial record
- 02 Dec 2021 According to the Biofrontera Inc media release, this trial is expected to initiate in 2022.